The Association of Blood Haemoglobin and Colour of Gums

Sponsor
KLE Society's Institute of Dental Sciences (Other)
Overall Status
Unknown status
CT.gov ID
NCT03791957
Collaborator
(none)
60
12

Study Details

Study Description

Brief Summary

AIM:

To evaluate the association of the levels of blood haemoglobin to the distribution and severity of gingival melanin pigmentation at 3 different periodontal health status

SAMPLE SIZE ESTIMATION

  • Done using GPower v.3.1.9.2

  • Total sample size = 60 (20 each in 3 groups)

  • Effect size = 40%

  • Power = 80%

  • α-error = 5%

SAMPLING:
  • Simple random sampling

  • Subjects to be recruited from out patient pool of KLE Society's Institute of Dental Sciences, Bangalore

  • Subjects to be categorised into 3 groups (20 subjects each)

  1. Group A - Healthy periodontium

  2. Group B - Gingivitis

  3. Group C - Periodontitis

PARAMETERS ASSESSED

  • Blood Haemoglobin Concentration (in %gm/dL)

  • Hedin Melanin Index Score 0: No pigmentation Score 1: one or two solitary unit(s) of pigmentation in papillary gingiva without formation of a continuous ribbon between solitary units Score 2: More than three units of pigmentation in papillary gingiva without the formation of a continuous ribbons of pigmentation Score 3: One or more short continuous ribbons of pigmentation Score 4: One continuous ribbon including the entire area between canines

STATISTICAL ANALYSIS

  • SPSS for Windows Version 22.0 to be used

  • Descriptive statistics: It includes expression of study parameters in terms of Mean & SD for continuous variables, whereas in terms of frequency and proportions for categorical variables.

  • Inferential Statistics:

Chi Square Test will be used to compare the pigmentation index between 03 groups. And similarly, gender wise comparison of hemoglobin concentration will be done using the same test.

One-way ANOVA test followed by Tukey's HSD post hoc Analysis will be used to compare the mean hemoglobin levels based on the pigmentation index scores in each group.

The level of significance [P-Value] was set at P<0.05

Condition or Disease Intervention/Treatment Phase
  • Other: Blood Haemoglobin

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
60 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
The Association of the Levels of Blood Haemoglobin to the Distribution and Severity of Gingival Melanin Pigmentation at 3 Different Periodontal Health Status
Anticipated Study Start Date :
Dec 20, 2019
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Group A - Healthy Periodontium

Absence of clinical signs of inflammation like bleeding on probing, erythema, edema, attachment loss, bone loss, patient symptoms, (bone levels at 1-3mm apical to CEJ) n=20

Other: Blood Haemoglobin
Routine haemotological investigation of blood haemoglobin levels in gm/dL will be recorded from withdrawn venous blood

Group B - Gingivitis

Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla, n=20

Other: Blood Haemoglobin
Routine haemotological investigation of blood haemoglobin levels in gm/dL will be recorded from withdrawn venous blood

Group C - Periodontitis

Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla,periodontal pocketing, clinical attachment loss, radiographically assessed bone loss n=20

Other: Blood Haemoglobin
Routine haemotological investigation of blood haemoglobin levels in gm/dL will be recorded from withdrawn venous blood

Outcome Measures

Primary Outcome Measures

  1. Blood Haemoglobin to Melanin pigmentation [Baseline]

    To assess the association of the levels of blood haemoglobin to the distribution and severity of gingival melanin pigmentation at 3 different periodontal health status by Hedin Melanin Index both by intragroup comparison within each of the 3 groups and intergroup comparison between the three groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Systemically healthy individuals

  • Absence of pathological gingival pigmentation

  1. Group A - Healthy Periodontium: Absence of clinical signs of inflammation like bleeding on probing, erythema, edema, attachment loss, bone loss, patient symptoms, (bone levels at 1-3mm apical to CEJ)

  2. Group B - Gingivitis: Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla,

  3. Group C - Periodontitis: Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla,periodontal pocketing, clinical attachment loss, radiographically assessed bone loss

Exclusion Criteria:
  • Tobacco associated pigmentation - smoker's melanosis, chewing/ pouching tobacco

  • Pigmentation from exogenous pigments - amalgam tattoo, cultural tattooing, beverages, food colours, betelnut/khat chewing, heavy metals ( mercury, silver, arsenic, bismuth, graphite, lead), topical medications, other foreign bodies

  • Pigmentation from endogenous pigments - jaundice, ecchymosis/ petechiae, haemochromatosis, hemosiderin

  • Long term consumption of pigmentation causing drugs - ACTH, antimalarial drugs, busulfan, doxorubicin, minocycline, oral contraceptives, phenothiazies

  • Syndromes and systemic diseases associated with pigmentation - Addison's disease. Albright's syndrome, basila melanosis, β-thalassemia, healed / healing mucocutaneous lesions, hereditary hemorrhagic Telangiectasia, HIV-associated melanosis, Neurofibromatosis, Peutz Jeghers syndrome, hamartoma, pyogenic granuloma, epulis

  • Benign or malignant lesions involving gingival - angiosarcoma, hemangioma, Kaposi's sarcoma, malignant melanoma, melanocytic nevus, pigmented vaculoe

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • KLE Society's Institute of Dental Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Riya Achamma Daniel, Post graduate student, Principal investigator, Department of Periodontics, KLE Society's Institute of Dental Sciences, Bangalore, KLE Society's Institute of Dental Sciences
ClinicalTrials.gov Identifier:
NCT03791957
Other Study ID Numbers:
  • riya2pigmentation
First Posted:
Jan 3, 2019
Last Update Posted:
Dec 17, 2019
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2019